Price
No data yet.
Social Signal Score
Revenue
$58.09M+152.40%Company Profile
- CEO
- Charles Choon Sik Park
- Sector
- Financial Services
- Industry
- Asset Management
- Beta
- 0.67
- Country
- US
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 0.71
Financials
Revenue
$58.09M+152.4%Net Income
$3.24M-86.8%EBITDA
$16.05M-16.2%Free Cash Flow
$32.05M+165.2%EPS (diluted)
$0.03-95.7%Shares Outstanding (diluted)
125.01M+205.1%Operating Expenses
$0.00Cash & Debt
$45.31MReturn of Capital
$38.35MDividend per Share
$0.05Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2026 | $100.79M | $91.30M | $0.96 |
| 2025 | $82.69M | $-74.23M | $-0.79 |
| 2024 | $38.10M | $38.04M | $0.40 |
| 2023 | $-29.73M | $-29.87M | $-0.31 |
| 2022 | $47.92M | $-94.93M | $-0.97 |
| 2021 | $35.80M | $35.64M | $0.87 |
| 2020 | $38.41M | $38.34M | $0.94 |
| 2019 | $45.01M | $45.02M | $1.10 |
| 2018 | $6.88M | $6.91M | $0.17 |
| 2017 | $-9.93M | $-10.00M | $-0.24 |
| 2016 | $42.99M | $67.06M | $43671190.00 |
| 2015 | $41.39M | $31.60M | $0.77 |
| 2014 | $43.00M | $88.75M | $2.16 |
| 2013 | $45.46M | $-39.44M | $-0.96 |
Valuation
Project earnings forward and see what return today's price implies.
EPS was negative in at least one boundary year, so a compound growth rate can't be computed from it. Set your own assumption.
- EPS in 5 years
- $1.41
- Implied price
- $15.52
- Return from $9.78
- 9.7% a year
To earn 15.0% a year on these assumptions you'd need to buy at $7.71 — -21.1% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 7 | 9 | 11 | 13 | 15 |
|---|---|---|---|---|---|
| -2.0% | -9.1% | -4.4% | -0.5% | 2.9% | 5.9% |
| 3.0% | -4.4% | 0.5% | 4.6% | 8.1% | 11.3% |
| 8.0% | 0.2% | 5.4% | 9.7% | 13.4% | 16.7% |
| 13.0% | 4.8% | 10.2% | 14.7% | 18.6% | 22.1% |
| 18.0% | 9.5% | 15.1% | 19.8% | 23.9% | 27.5% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
10-93.10%Social Signal Score
Mentions (3)
- Newsglobenewswire.com·1d ago·Negative
ArriVent Announces First Patient Dosed with Novel Tetravalent MUC16/NaPi2b Dual Target ADC, ARR-002 NEWTOWN SQUARE, Pa., Oct. 12, 2026 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced that it dosed its first patient in the Phase 1 trial in the U.S. with ARR-002 (NCT07755436), a potential first-in-class MUC16/NaPi2b dual-target t…
View source ↗ - Newsglobenewswire.com·13d ago·Positive
Ubamatamab (MUC16xCD3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (LGSOC) LGSOC is a biologically distinct variant of ovarian cancer, with limited treatment options, that is generally less responsive to conventional chemotherapy
View source ↗ - Newsprnewswire.com·13d ago·Negative
Whitehawk Therapeutics Presents Real-World Analyses Supporting MUC16 as a Durable ADC Target in Ovarian Cancer at IGCS 2026 MUC16 Expression Remained High and Stable Following Standard-of-Care Therapies, Supporting Its Potential Utility in Both Combination Approaches and Relapsed Settings High MUC16 Expression Was Associated with Poor Real-World Overall Survival in High-Grade Serous Ovarian Carcinoma, the Most Common Subtype of Ovarian Cancer Findings Reinforce the Scientific Rationale for HWK-0…
View source ↗
Insider trading
Open-market buys and sells by MUC officers and directors.
- Bought
- $1k
- Sold
- —
2 trades
0 trades
- Harris Stayce D.bought
- Cavanagh Richardbought
85 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in MUC.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.